A case of temporal arteritis successfully treated with recombinant interleukin-2

Area of Science:

• Immunology
• Rheumatology
• Oncology

Background:

• Temporal arteritis is a form of vasculitis affecting large arteries, primarily the temporal arteries.
• Systemic inflammation and symptoms like headache and skin necrosis characterize the condition.
• Current treatments aim to reduce inflammation but can have significant side effects.

Observation:

• An 80-year-old Japanese female patient diagnosed with temporal arteritis was administered recombinant human interleukin-2 (IL-2).
• The patient received a dosage of 1 x 10(6) units per day for a duration of six weeks.
• Clinical symptoms including headache and skin necrosis were monitored alongside laboratory markers such as erythrocyte sedimentation rate and C-reactive protein (CRP).

Findings:

• The patient exhibited prompt improvement in presenting symptoms of headache and skin necrosis.
• Abnormal laboratory findings, including elevated erythrocyte sedimentation rate and CRP, showed significant reduction.
• No serious adverse side effects were reported during the IL-2 treatment course.

Implications:

• This case report suggests a potential therapeutic role for interleukin-2 (IL-2) in managing temporal arteritis.
• Further research is warranted to elucidate the underlying mechanisms of IL-2's efficacy in vasculitis.
• IL-2 may offer a novel treatment option for temporal arteritis, potentially with a favorable safety profile.